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Abstract
Background: Improvements in communication and information technologies have allowed for the globalisation
of health services, especially the provision of health services from other countries, such as the use of telemedicine.
This has led countries to evaluate their position on whether and to what extent they should open their health
systems to trade. This often takes place from the context of multi-lateral trade agreements (under the auspices
of the World Trade Organisation), which is misplaced as a significant amount of trade takes place regionally or
bi-laterally. We report here the results of a qualitative study assessing stakeholders’ views on the potential for a
bi-lateral trade relationship between India and the UK, where India acts as an exporter and the UK as an importer
of telemedicine services.
Methods: 19 semi-structured interviews were carried out with stakeholders from India and the UK. The themes
discussed include prospects on the viability of a bi-lateral relationship between the UK and India on telemedicine,
current activities and operations, barriers, benefits and risks.
Results: The participants in general believed there were good prospects for telemedicine trade, and that this could
bring benefits to “importing” countries in terms of cost-savings and faster delivery of care and to “exporting”
countries in the form of foreign exchange and quality improvement. However, there were some concerns
regarding quality of care, regulation, accreditation and data security.
Conclusions: There is potential for trade in this type of health services to succeed and bring about important
benefits to the countries involved. However, issues around data security and accreditation need to be taken into
consideration. Countries may wish to consider entering bi-lateral agreements, as they provide more potential to
address the concerns and capitalise on the benefits. Finally, this paper concludes that more data should be
collected, both on the volume of telemedicine trade and on the impact it is having on health systems, as currently
there is very limited data on this.
Background
With increasing globalisation countries have been open-
ing their service sectors to international trade. Health
services are no exception to this. Although most trade
in health services occurs through regional and bi-lateral
routes [1], research on this topic has centred on multi-
lateral agreements signed under the World Trade Orga-
nisation’s General Agreement on Trade in Services
(GATS) [2]. This multi-lateral agreement is a system of
rules through which international trade in services
occurs, and by which all member countries trade with
each other. There are fears that trade in health services
will accelerate privatisation of health systems [3] and
hinder domestic health policy decision-making [4]. On
the other hand, some studies have highlighted that
increased health services trade and outsourcing can
facilitate the sharing of ideas and reform, and improve
the sustainability of health systems [5]. However, there
is little data to support or refute these claims.
This study is set in the context of a specific mode of
trade in health services, telemedicine. Telemedicine is
the application of telecommunications technology to
deliver health services at a distance [6]. Telemedicine
trade is already taking place on a large scale, with the
global market estimated to be worth $5.8 billion in
2007, and projected to grow to $13.9 billion by 2012 [7].
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There are different types of health care services that can
be outsourced, although the most important ones are
tele-radiology and tele-pathology. These involve scans or
samples being sent to radiologists or pathologists for
interpretation in a remote location, who then send the
results back to the physician. A sector of telemedicine
that has received increasing attention is tele-care. Tele-
care involves the use of information and communication
technologies to monitor patients (often suffering from
chronic diseases) from their home. It has already been
trialled in United States [8], Chile [9] and Taiwan [10].
Further, there are plans to establish tele-care initiatives
in remote parts of Scotland and Canada.
The growing use of telemedicine has prompted a body
of literature on the benefits and concerns associated
with it. The authors have previously conducted a litera-
ture review on telemedicine, exploring the issues that
arise from cross-border trade globally, and specifically
using the UK and India as a case study [11]. This review
found that while trade in telemedicine services has the
potential to benefit both the exporting and importing
countries by allowing for faster service delivery and rais-
ing foreign exchange, there are concerns regarding data
security, recognition of qualifications and legal liability
[12]. The literature review had two main conclusions.
First, very little data was found on the amount of trade
in telemedicine that is currently taking place or on the
issues associated with it. It is therefore important that
more studies are carried out on this, both at the global
and at the country level. Second, that were countries to
consider this type of trade in health services from a bi-
lateral perspective, they could maximise the benefits and
minimise the concerns. This is because a contract would
be drawn out between the two countries, where condi-
tions can be agreed upon, such as outlining data regula-
tions and security, litigation procedures and liability,
and regulation and recognition of qualifications.
With the aim of contributing to the limited evidence
base on cross-border trade of telemedicine services, the
authors conducted semi-structured interviews with stake-
holders in both India and the UK, to seek their opinions
on the prospects for a telemedicine trade relationship
between these two countries, where India would provide
telemedicine services to the UK. Further, the potential
benefits and barriers that may arise from this type of rela-
tionship were assessed. In doing this, the authors have
undertaken a social science perspective to address a gap
in the knowledge available regarding telemedicine trade,
and hope to contribute to the limited data available to
inform countries considering opening their health ser-
vices to international trade. This paper describes the
methodology used to carry out the research, followed by
the results from the interviews and the discussion. The
paper concludes with key messages.
Methods
A total of 19 interviews were carried out with stake-
holders; of these, eight were from the UK and 11 from
India (see table 1). The stakeholders that took part in
the study were identified as important from the litera-
ture review carried out previously [11]. A snowball sam-
pling technique was then used to identify the other
stakeholders. The interviews were semi-structured [13]
to allow for additional issues not identified in the litera-
ture review to be included in the study. As such, a qua-
litative instrument was designed based on the findings
from the literature review (see Additional File 1 for an
example). The instrument was adapted for each stake-
holder as appropriate.
The interviews were carried out by one of the authors
in India (RC) and another author in the UK (MMA).
The interviews were mainly conducted face-to-face,
although some of the Indian participants were inter-
viewed over the phone. Answers were recorded by hand
and typed up. The interviewers were in regular contact
during the interview process to discuss emerging
themes. The interviews were examined using content
analysis [14]. Briefly, each script was reviewed and cod-
ing categories were identified. The scripts were then
analysed using these coding categories. The coding fra-
mework consisted of both emergent and a priori coding
categories [14]. Coding categories were designed based
on the themes identified during the literature review
[11]. The transcripts were then reviewed and any new
coding categories that arose was incorporated. Any new
themes that emerged were explored across all the inter-
view transcripts. This process was iterated until no
more new categories emerged (see table 2 for a full list
of all coding categories). The coding framework was
developed by MMA and reviewed by the other authors
until an agreement was reached. Once the list of coding
categories was compiled, the interview transcripts were
analysed using these codes. The coding units were any
sentences or paragraphs that fell under any of the cod-
ing categories. The analysis was conducted by MMA,
Table 1 List of stakeholders that took part in the semi-
structured interviews
Stakeholder group Country Stakeholder Number
Department of Health UK 1, 2, 3, 4
Healthcare provider UK 5, 7
Healthcare provider India 9, 11, 12, 14, 15, 17, 18
Think tank UK 8
NGO India 10
Academic India 16
Industry association UK 6
Industry association India 13
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although any ambiguities identified were discussed with
the other authors.
Results
A summary of all the coding categories and their fre-
quency according to stakeholder is shown on table 2.
Current activities
The participants were asked about the current cross-
border telemedicine activities their country engages in.
The respondents highlighted that both the UK and India
engage in international trade of telemedicine. The UK
was said to have arrangements for the remote provision
of diagnostic services with South Africa and Belgium,
whereas India was reported to outsource health services
to Singapore.
However, there was disagreement with regards to cur-
rent activities between the UK and India amongst the
UK stakeholders, as some believed the UK does not
import any telemedicine services from India while
others believed that it does.
There have already been agreements to outsource back
office work, and some contracts have been with India.
These contracts have been running for two years ... But
so far, it has only been the non-clinical work that has
been outsourced (Respondent #4)
The UK is currently outsourcing its back office work to
India. It also has massive contracts with Indian compa-
nies to carry out X rays, diagnostic reporting, communi-
cation processes ... Lab work will also be transferred to
India ... Doctors also send their recordings from their
consultations, and overnight they are transcribed, printed
and filed (Respondent #6)
Prospects
Over half of the respondents commented on the pro-
spects for telemedicine trade. In general, most were
optimistic about the prospects for telemedicine, either at
the national or the international level. The UK stake-
holders were particularly optimistic.
There is no reason why information on some areas of
treatment (X-ray, glucose levels) can’t be transmitted to
India ... There is real potential not to be bound by
national borders (Respondent #8)
However, the respondents thought that this will take
time.
The technology is here to stay. However, it will be evo-
lutionary rather than revolutionary ... telemedicine will
start in-country first, before going across borders
(Respondent #7)
The response from the Indian stakeholders was mixed.
Whilst some believed there was great potential for tele-
medicine trade between the UK and India, others were
of the opinion that the UK would not be their prime
market, at least not in the near future.
The size of the market is big for telemedicine ... The
UK is not that big a potential market ... There is some
potential for NHS outsourcing of radiology services but it
will be quite a while before this happens and certainly
not in the next five years or so (Respondent #14)
The best prospects are with countries in Africa and in
other poor countries where there aren’t sufficient number
Table 2 Coding categories and frequency by group
Coding Category1 Frequency by groups
Government officials Healthcare providers Industry associations Others 2
UK India UK India UK India UK India
Prospects 2 1 1 5 1 1 1
Sectors 2 8 1 1 1 1
Advantages 1 1 1 2
Regulation 1 4 1
Quality 2 1 1 1
Litigation 2 2
Data safety 1 1 4
Other barriers 1 1 5 1 1 1
Policy issues 1 5 1 1
1 The coding categories were identified from the interview transcripts. They are described here. Prospects: the participants were asked their opinion on
telemedicine trade globally and between the UK and India. Sectors: the stakeholders were asked to identify which sectors within telemedicine would be most
successful from an international trade perspective. Advantages: Participants were asked what advantages trade in telemedicine would bring to the countries
involved. Regulation: the respondents identified regulation as a key barrier to trade in telemedicine. Quality: similarly, stakeholders were concerned about the
standards of care that telemedicine could offer, especially if provided from another country. Litigation: many participants were concerned about the legal
implications of malpractice in cross-border telemedicine. Data safety: restrictions from the European Union (EU) on India’s data management were highlighted as
a key constraint. Other barriers: this category summarises all the other barriers identified by the stakeholders interviewed. Policy issues: respondents were asked
to identify policy changes that would be needed for a relationship between the UK and India to take off.
2 Think tanks, NGOs and academic institutions.
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of trained people ... In the UK, the chances of doing tele-
medicine with them is not good (Respondent #17)
Both sets of stakeholders agreed that the UK prefers
the services to be delivered from the UK, even if this is
done by a foreign provider. This is again contradictory
to the notion that the UK is outsourcing some of its
diagnostic services to India.
The UK welcomes bids from providers from all coun-
tries that can deliver contracts, but need to provide ser-
vices from the UK, to ensure quality and contract terms
(Respondent #1)
Sectors
When asked about which segments of telemedicine have
most potential for international trade, most respondents
identified diagnostic services, especially radiology and
pathology.
Telemedicine can be used for treatment as well as for
diagnostics ... The UK is not ready to use telemedicine
for direct treatment for now (Respondent #1)
The segments of focus in India are tele-radiology and
tele-pathology (Respondent #10)
The UK stakeholders made a further distinction
between telemedicine and tele-care, with the latter being
favoured.
In the UK in the last 5 years, the main opportunities
have shifted from telemedicine to tele-care (supporting
people in the community, monitoring them from the
home) ... Tele-care is the major drive now ... This is part
of the wider public health agenda, to support individuals
in their homes. There is a policy agenda now of self-care
and chronic disease management. In commercial terms,
there has been recent growth in technologies that would
facilitate these services ... internationally ... this has not
been addressed in any major way (Respondent #3)
It [tele-care] can still be of use in the UK, as it would
allow people to be monitored from home, rather than in
hospital. They could talk daily to nurses on screens.
There are plans to do this in the NHS, to use remote
monitoring for chronic conditions, without the patient
having to go in to hospital (Respondent #6)
Advantages
The stakeholders identified several advantages to
importing health services via telemedicine, both for the
UK and for India. In terms of the UK, participants iden-
tified saving time and money as the key advantages of
telemedicine
It is part of driving down cost and improving efficiency
(Respondent #6)
Whereas in India, asides from an increase in revenues,
the importance of telemedicine trade in improving the
national health system and the country image were
highlighted as key advantages
We could use telemedicine exports as a way to inno-
vate and to catalyze and redesign our health system
(Respondent #10)
The main benefits would be revenues, positive interna-
tional exposure, opportunities to give back to the com-
munity in terms of training and corporate social
responsibility work (Respondent #15)
Regulation, quality and litigation
One of the main concerns expressed by the respondents
was whether the services offered by telemedicine would
be of the same standard as those provided by the UK
National Health Service.
The main problem would be how to maintain stan-
dards ... in diagnostics, would there be a discrepancy in
the result if someone had the test done in India or in the
UK? The service could be potentially opening to a dual
standard (Respondent #5)
This was linked to problems and difficulties that
would arise when trying to regulate health service provi-
ders that were based in a different country. Indian stake-
holders recognised this as a barrier, and understood the
need of being accredited. However, they showed discon-
tent at the length and cost of the process. Additionally,
there are concerns about litigation, and who would be
responsible should there be any malpractice.
In terms of treatment the EU law is unclear on respon-
sibilities if something goes wrong (Respondent #1)
Where would any malpractice be tried, in the UK
Court of Law or in the Indian Consumer Forum?
(Respondent #17)
Other barriers
When asked about the potential barriers that may hin-
der an India-UK bi-lateral relationship in telemedicine,
many stakeholders agreed that data safety would be the
biggest worry.
India has been deemed “data unsafe” by the EU, and
in that respect the UK cannot make any contracts with
them (Respondent #1)
We need to have a data protection law. The IT [Infor-
mation Technology] act is not enough (Respondent #10)
However, not everyone agreed about the importance
of data safety, with some stakeholders thinking it was
more of an excuse than a real issue.
Data security is a made up issue. If it was a real issue
the UK (or EU) would give India a list of things that
have to improve for telemedicine trade to take place and
India would oblige (Respondent #9)
There is a large volume of reporting that is done by
South Africa for the UK and so why data protection is
an issue for India is not clear (Respondent #15)
One UK stakeholder did not even believe the EU had
placed any restrictions on data safety:
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There are no barriers from the EU (Respondent #6)
There was also some discussion on how this barrier
could be overcome:
The Indian government has to take the case to Brus-
sels, and the UK would not stand in the way of that
(Respondent #1)
Another important concern for the UK stakeholders
was public acceptance, with members of the Department
of Health particularly worried a move to providing some
services through telemedicine would prove unpopular
with the British population.
People wouldn’t accept it; they would accuse the gov-
ernment of putting them at risk in order in order to cut
costs (Respondent #1)
How it looks and feels to the end user is also very
important. Would it be acceptable? They would see it as
a cost-cutting measure; it would be an admission of fail-
ure (Respondent #2)
Furthermore, some of the Indian respondents were
also worried about the impact exporting telemedicine
services would have on the local, Indian population.
There is concern that there could be an adverse impact
for the local health system. Doing tele-pathology or tele-
radiology could reduce the quality of such services for the
domestic population by diverting resources from domestic
services (Respondent #17)
Both the UK and Indian stakeholders interviewed
identified protectionism and pressure from unions and
the General Medical Council (GMC) as an important
barrier for this type of trade in health services
This [telemedicine] is unlikely to happen on a big scale
unless there is some change around protectionism ... peo-
ple, politics, money and greed (Respondent #7)
Professional organisations would also pose problems.
The unions would raise objections based on risk and
clinical competency, whilst these may be valid, the main
reason would be job protection (Respondent #7)
It is important for doctors to trust their colleagues,
which would be harder if they do not meet face to face,
and they don’t get to know them, know their background
(Respondent #8)
Finally, there were some concerns from the UK stake-
holders that telemedicine may not deliver as good a ser-
vice as traditional care.
Telemedicine raises questions about the alternative,
traditional methods of care: is it supporting people? Is it
preventing important elements of clinical care? Is it
going to limit person-person contact? Is something lost if
doctor can’t see/feel the patient? (Respondent #3)
Policy
The participants were asked about what policy changes
would be needed for a UK-India trade relationship in
telemedicine to be formalised. There was some
disagreement between the stakeholders on this. Some of
the UK participants believed no changes would be
needed,
There wouldn’t need to be a policy change per se. It
would be up to individual trusts to look at more innova-
tive ways of working, keeping safety in mind (Respondent
#4)
whilst others thought a fundamental change in the
NHS and Department of Health needs to take place:
Changes are needed; it is a hearts and minds, money
and skills operation. But they need to have the policy
and authority to make changes to introduce telemedicine
in a meaningful way, at the moment it is small, uncoor-
dinated and fragmented ... Technologies moves quickly
and the NHS very slowly! There is no pull mechanism,
only push from industry (Respondent #6)
From the Indian side, the healthcare providers that
took part in the study felt that the government should
be more involved in facilitating telemedicine exports, by
improving India’s image, working with private sector
and facilitating trade.
There should be support of telemedicine with incentives
such as subsidies (Respondent #11)
There need to be certain initiatives, like establishing
infrastructure of a certain standard, speed of communi-
cation, its dependability, and security (Respondent #12)
However, this was opposed by the government:
The government will not look at telemedicine for
exports. This needs to be used domestically (Respondent
#19)
Additionally, many of the stakeholders felt policy solu-
tions were needed for some of the barriers mentioned,
including regulation, data protection and malpractice. In
addition, some participants highlighted that these bar-
riers would be better addressed through a bi-lateral
trade relationship.
The documentation requirements are very onerous.
NHS processes need to be streamlined ...
The GMC registration process should be simplified and
expedited ... The Indian providers will need to show
higher quality of work (Respondent #15)
Data protection ... could be addressed through bilateral
agreements (Respondent #10)
There are issues of compensation in case of misdiagno-
sis and misreporting, though these can be taken care of
through the contract and its enforcement (Respondent
#17)
Discussion
The views of the stakeholders on the prospects for a bi-
lateral trade relationship between the UK and India are
summarised in table 3. The results from the semi-
structured interviews show that there are a number
of issues where stakeholders in both countries agree.
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These include good global prospects for trade in teleme-
dicine services, the key sectors being diagnostic (mainly
tele-radiology and tele-pathology), concerns regarding
quality and litigation, the main advantages being saving
time and money from the UK side, and generating reven-
ues from the Indian side, and protectionism and lack of
recognition being key barriers. These are also in agree-
ment with the findings of the literature review previously
carried out by the authors [11].
On the other hand, the participants disagreed on a
number of issues. For instance, most of the UK and
some of the Indian stakeholders believed that there were
good prospects for a bi-lateral relationship in telemedi-
cine services between the UK and India, whereas many
of the Indian stakeholders were less optimistic. One
important issue where there was disagreement was on
the current activities of telemedicine cross-border trade
taking place between the UK and India. Whilst some of
the UK interviewees and most of the Indian participants
believed there was no such trade taking place, other UK
stakeholders argued that major contracts had been
agreed by the NHS with Indian firms. This is an impor-
tant issue to resolve as if this type of trade is indeed tak-
ing place, data can be collected on its viability and
impact on both countries. It would also mean that these
agreements have taken place despite the barriers men-
tioned in this study, and how this can take place should
also be examined in more detail.. Other areas where
there was disagreement include the importance of tele-
care, which the Indian stakeholders were not aware of,
whether data safety was a real barrier and what policy
measures would be needed for a bi-lateral telemedicine
trade relationship between the UK and India to be
agreed.
It is interesting to see that some of the stakeholders
called for a bi-lateral relationship to address some of the
concerns and barriers involved with telemedicine trade.
This is in agreement with the results of the literature
review carried out by the authors [11], which concluded
that in a bi-lateral relationship between the UK and
India, both countries would sign a contract which would
pre-establish the data safety procedures to be followed,
the qualifications needed to provide services to UK
patients, protocols in the event of malpractice, as well as
mechanisms to ensure the local population in India and
their health system benefit from the revenues such
arrangement would bring. This would not be possible
under a GATS-based multi-lateral trade scenario, where
all countries can trade with each other and are not able
to pre-establish this sort of pre-conditions.
This research is subject to several biases. First,
although a common interview tool was used, the inter-
views were carried out by two different researchers, one
based in India and one in the UK. This could have lead
to questions being asked with different emphasis and
answers recorded differently. Additionally, the sample
size is small, and the opinion of the stakeholders that
refused to take part, or any that may have not been
identified, is therefore not included.
Nonetheless, some important policy recommendations
can be made from the findings of this research. The main
barrier reported was data safety and EU restrictions on
dealing with India. It is therefore essential for the Indian
government and companies planning on providing tele-
medicine services to the UK to ensure they are complying
with the regulations and that other restrictions on this
type of trade are lifted. Additionally, India should estab-
lish national data protection legislation and the UK (or
the EU) should set up a system of accreditation for tele-
medicine providers. Other barriers include concerns
regarding quality, regulation and litigation. Here, the UK
should streamline and ease the processes required to be
registered with the GMC, and India should aim for
accreditation and quality assurance. In terms of sectors,
it appears that telemedicine will mainly succeed for diag-
nostic services. Additionally, the UK stakeholders identi-
fied tele-care as a key sector, which the Indian health
service providers should capitalise in. Further, if both
Table 3 Summary of stakeholder opinion on telemedicine trade between the UK and India
UK India
Current activities Currently importing telemedicine services Currently exporting telemedicine services
Prospects for telemedicine trade Good Good, but with the UK in the short-term
Sectors Diagnostic services, tele-care Mainly diagnostic services
Advantages Lower costs of health care
Increased efficiency
Higher revenues
Improve health system
Boost country image
Barriers Quality
Malpractice
Public acceptance
Data safety
Regulation
Impact on local health care
Protectionism
Policy solutions Change in mentality Government involvement
Bi-lateral agreement
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countries were to enter into a bi-lateral agreement on
trade in health services, they would need to outline litiga-
tion procedures to be followed should a case of malprac-
tice arise, ensure the revenues generated are spent on
India’s health system, so the local population benefits,
and choose the sectors where public resistance will be
minimal (i.e. those where there is no interaction with the
patient, such as pathology). Finally, telemedicine should
also be raised in the ongoing EU-India trade negotiations,
which cover trade in services between the EU and India.
Additional material
Additional file 1: Discussion guide used to conduct the interviews
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